H5N1 influenza vaccine (MediVas)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameH5N1 influenza vaccine (MediVas)
Drug Alias Nameavian influenza vaccine (MediVas)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins stimulants
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMediVas LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediVas LLC
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A